{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:16:05Z","timestamp":1787814965240,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejpb.2023.01.026","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T20:50:43Z","timestamp":1675457443000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparison of barrier properties of outer blood-retinal barrier models \u2013 Human stem cell-based models as a novel tool for ocular drug discovery"],"prefix":"10.1016","volume":"184","author":[{"given":"Laura","family":"Hellinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-5673","authenticated-orcid":false,"given":"Heidi","family":"Hongisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati-Sisko","family":"Vellonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-8792","authenticated-orcid":false,"given":"Heli","family":"Skottman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1369-9565","authenticated-orcid":false,"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.01.026_b0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejpb.2023.01.026_b0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.008","article-title":"Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation","volume":"143","author":"Ramsay","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2023.01.026_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.ejpb.2023.01.026_b0020","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global Prevalence of Age-Related Macular Degeneration and Disease Burden Projection for 2020 and 2040: A Systematic Review and Meta-Analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ejpb.2023.01.026_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal Clearance and Volume of Distribution of Compounds in Rabbits. In Silico Prediction and Pharmacokinetic Simulations for Drug Development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2023.01.026_b0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an Animal Model for Intravitreal Pharmacokinetics: Clinical Predictability and Quality of the Published Data","volume":"137","author":"Del Amo","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2023.01.026_b0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2014.06.044","article-title":"A Critical Assessment of in Vitro Tissue Models for ADME and Drug Delivery","volume":"190","author":"Vellonen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.01.026_b0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.04-0925","article-title":"Functional Characterization and Comparison of the Outer Blood-Retina Barrier and the Blood-Brain Barrier","volume":"46","author":"Steuer","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity","volume":"46","author":"Pitkanen","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a Human Retinal Pigment Epithelial Cell Line with Differentiated Properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2023.01.026_b0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejps.2010.04.001","article-title":"Filter-Cultured ARPE-19 Cells as Outer Blood-Retinal Barrier Model","volume":"40","author":"Mannermaa","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of Melanin Binding in Ocular Drug Delivery","volume":"126","author":"Rimpela","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.01.026_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2018.05.034","article-title":"Melanin Targeting for Intracellular Drug Delivery: Quantification of Bound and Free Drug in Retinal Pigment Epithelial Cells","volume":"283","author":"Rimpela","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.01.026_b0070","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1021\/acs.jmedchem.8b01281","article-title":"Understanding Molecular Drivers of Melanin Binding to Support Rational Design of Small Molecule Ophthalmic Drugs","volume":"61","author":"Jakubiak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2023.01.026_b0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1167\/iovs.12-10169","article-title":"Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF\/PDGF RTK Inhibitors for Ocular Neovascular Disease","volume":"54","author":"Robbie","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50324-8","article-title":"Characterization of Artificially Re-Pigmented ARPE-19 Retinal Pigment Epithelial Cell Model","volume":"9","author":"Hellinen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2023.01.026_b0085","doi-asserted-by":"crossref","unstructured":"Pelkonen, L.; Reinisalo, M.; Morin-Picardat, E.; Kidron, H.; Urtti, A. Isolation of Intact and Functional Melanosomes from the Retinal Pigment Epithelium. PLoS ONE 2016, 11, e0160352.","DOI":"10.1371\/journal.pone.0160352"},{"key":"10.1016\/j.ejpb.2023.01.026_b0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 Clinical Study of an Embryonic Stem Cell-Derived Retinal Pigment Epithelium Patch in Age-Related Macular Degeneration","volume":"36","author":"da Cruz","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2023.01.026_b0095","first-page":"283","article-title":"Molecular Characterization and Functional Analysis of Phagocytosis by Human Embryonic Stem Cell-Derived RPE Cells using a Novel Human Retinal Assay","volume":"15","author":"Carr","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2023.01.026_b0100","first-page":"558","article-title":"Toward the Defined and Xeno-Free Differentiation of Functional Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells","volume":"17","author":"Vaajasaari","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2023.01.026_b0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12015-017-9754-0","article-title":"Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium","volume":"13","author":"Bennis","year":"2017","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.ejpb.2023.01.026_b0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13287-017-0738-4","article-title":"Xeno- and Feeder-Free Differentiation of Human Pluripotent Stem Cells to Two Distinct Ocular Epithelial Cell Types using Simple Modifications of One Method","volume":"8","author":"Hongisto","year":"2017","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.ejpb.2023.01.026_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06233-9","article-title":"Comparative Proteomic Analysis of Human Embryonic Stem Cell-Derived and Primary Human Retinal Pigment Epithelium","volume":"7","author":"Hongisto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2023.01.026_b0120","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1016\/j.biomaterials.2012.07.033","article-title":"Generation of hESC-Derived Retinal Pigment Epithelium on Biopolymer Coated Polyimide Membranes","volume":"33","author":"Subrizi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2023.01.026_b0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yexcr.2017.08.004","article-title":"Contacting Co-Culture of Human Retinal Microvascular Endothelial Cells Alters Barrier Function of Human Embryonic Stem Cell Derived Retinal Pigment Epithelial Cells","volume":"359","author":"Skottman","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejpb.2023.01.026_b0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2017.07.027","article-title":"Melanin Binding Study of Clinical Drugs with Cassette Dosing and Rapid Equilibrium Dialysis Inserts","volume":"109","author":"Pelkonen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acs.molpharmaceut.6b00782","article-title":"LC-MS\/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line","volume":"14","author":"Pelkonen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.01.026_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11626-010-9286-2","article-title":"Derivation and Characterization of Three New Human Embryonic Stem Cell Lines in Finland","volume":"46","author":"Skottman","year":"2010","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.ejpb.2023.01.026_b0145","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.xphs.2017.04.061","article-title":"Impact of Chemical Structure on Conjunctival Drug Permeability: Adopting Porcine Conjunctiva and Cassette Dosing for Construction of in Silico Model","volume":"106","author":"Ramsay","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0150","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/term.2089","article-title":"A Bruch\u2019s Membrane Substitute Fabricated from Silk Fibroin Supports the Function of Retinal Pigment Epithelial Cells in Vitro","volume":"11","author":"Shadforth","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ejpb.2023.01.026_b0155","first-page":"60","article-title":"Appropriately Differentiated ARPE-19 Cells Regain Phenotype and Gene Expression Profiles Similar to those of Native RPE Cells","volume":"23","author":"Samuel","year":"2017","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2023.01.026_b0160","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1167\/iovs.02-0287","article-title":"Polarized Expression of Monocarboxylate Transporters in Human Retinal Pigment Epithelium and ARPE-19 Cells","volume":"44","author":"Philp","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0165","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1167\/iovs.19-27328","article-title":"Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison between Apical and Basolateral Plasma Membranes with Emphasis on Transporters","volume":"60","author":"Hellinen","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0170","first-page":"622","article-title":"Structure and Barrier Properties of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells are Affected by Extracellular Matrix Protein Coating","volume":"20","author":"Sorkio","year":"2014","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.ejpb.2023.01.026_b0175","doi-asserted-by":"crossref","unstructured":"Viheri\u00e4l\u00e4, T.; Sorvari, J.; Ihalainen, T. O.; M\u00f6r\u00f6, A.; Gr\u00f6nroos, P.; Schlie-Wolter, S.; Chichkov, B.; Skottman, H., Nymark, S.; Ilmarinen, T. (2021). Culture surface protein coatings affect the barrier properties and calcium signalling of hESC-RPE. Sci. Rep. 2019, 11(1), 933.","DOI":"10.1038\/s41598-020-79638-8"},{"key":"10.1016\/j.ejpb.2023.01.026_b0180","unstructured":"European Medicines Agency. Guideline on the Investigation of Drug Interactions. 2012, PMP\/EWP\/560\/95\/Rev. 1 Corr. 2 **; Committee for Human Medicinal Products (CHMP): London, UK, 2012."},{"key":"10.1016\/j.ejpb.2023.01.026_b0185","doi-asserted-by":"crossref","unstructured":"Juuti-Uusitalo, K.; Vaajasaari, H.; Ryhanen, T.; Narkilahti, S.; Suuronen, R.; Mannermaa, E.; Kaarniranta, K.; Skottman, H. Efflux Protein Expression in Human Stem Cell-Derived Retinal Pigment Epithelial Cells. PLoS ONE 2012, 7, e30089.","DOI":"10.1371\/journal.pone.0030089"},{"key":"10.1016\/j.ejpb.2023.01.026_b0190","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/acs.molpharmaceut.5b00729","article-title":"Prediction of Ocular Drug Distribution from Systemic Blood Circulation","volume":"13","author":"Vellonen","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.01.026_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.12.009","article-title":"Expression, Activity and Pharmacokinetic Impact of Ocular Transporters","volume":"126","author":"Vellonen","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.01.026_b0200","first-page":"107","article-title":"Drug Distribution to Retinal Pigment Epithelium: Studies on Melanin Binding, Cellular Kinetics, and SPECT\/CT Imaging","volume":"57","author":"Rimpela","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.01.026_b0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2014.07.003","article-title":"A New Approach to Predict Human Intestinal Absorption using Porcine Intestinal Tissue and Biorelevant Matrices","volume":"63","author":"Westerhout","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"15","key":"10.1016\/j.ejpb.2023.01.026_b0210","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/ijms20153773","article-title":"Compromised barrier function in human induced pluripotent stem-cell-derived retinal pigment epithelial cells from type 2 diabetic patients","volume":"20","author":"Kiamehr","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2023.01.026_b0215","doi-asserted-by":"crossref","unstructured":"Sharma, R.; George, A.; Nimmagadda, M.; Ortolan, D.; Karla, B. S., Qureshy; Z., Bose, D.; Dejene, R.; Liang, G.; Wan, Q.; Chang, J.; Jha, B. S.; Memon, O.; Miyagishima, K. J.; Rising, A.; Lal, M.; Hanson, E.; King, R.; Campos, M. M.; Ferrer, M.; \u2026 Bharti, K. Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nat. Commun. 2021,12(1):7293.","DOI":"10.1038\/s41467-021-27488-x"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:51:52Z","timestamp":1760547112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"alternative-id":["S0939641123000310"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.026","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of barrier properties of outer blood-retinal barrier models \u2013 Human stem cell-based models as a novel tool for ocular drug discovery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}